QUALITY OF LIFE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER STAGES T2B AND T3A AFTER SURGICAL TREATMENT
https://doi.org/10.17650/1726-9776-2012-8-3-55-59
Abstract
The article represents the study of quality of life in patients with muscle-invasive bladder cancer stages T2b and T3a after surgery, depending on the operation type. The study was conducted using questionnaires EORTC QLQ-30 and FACT-BL. The best levels of quality of life were observed in patients after organ-saving treatment of muscle-invasive bladder cancer.
About the Authors
T. A. Sveklina
Department of Urology Nizhny Novgorod State Medical Academy, Nizhny Novgorod
Russian Federation
Russian Federation
V. N. Krupin
Department of Urology Nizhny Novgorod State Medical Academy, Nizhny Novgorod
Russian Federation
Russian Federation
References
1. Jichilinski P., Forrer M., Mizeret J. Clinical evaluation for detecting superficial transition cell carcinoma of the bladder by light — induced fluorescence of protoporphyrin IX following topical application of 5-aminolevulinic acid. Laser Surg Med 1997;29:402−8.
2. Step H., Wagner S., Zaak D., Knuchel R. Fluorescence diagnosis of bladder tumor by use of 5 — aminolevulinic acid: fundamentals and results. Ed. R. Baumgartner, M. Kreigmair, A. Hofstetter. 1998; р. 39−41.
3. Русаков И.Г., Соколов В.В., Булгакова Н.Н. и др. Фотодинамическая диагностика и флуоресцентная спектроскопия при поверхностном раке мочевого пузыря. Онкоурология 2009;4:41−6.
4. Карякин О.Б. Органосохранная тактика при инвазивном раке мочевого пузыря: «за» и «против». Практ онкол 2003; 4(4):252 −5.
5. Иванов С.Д., Маслюкова Е.А., Карелин М.И. и др. Прогнозирование эффективности органосохраняющего лечения больных инвазивным раком мочевого пузыря. Вопр онкол 2006;52(5):565−70.
6. Попов А.М., Карякин О.Б. Органосохраняющее лечение инвазивного рака мочевого пузыря. Рос онкол журн 2005;3:49−52.
7. Aaronson N.K., Ahmedzai S., Bergman B. et al. The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trilas in oncology. J Nat Cancer Inst 1993;85:365−75.
8. Fayers P., Aaronson N., Bjordal K., Sullivan M. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life, Brussels, 1995. P. 50.
9. Coast J., Peters T.J., Richards S.H., Gunnell D.J. Use of the EuroQOL among elderly acute care patients. Qual Life Res 1998;7:1:1−10.
10. Frei E. 3rd. Randomized clinical trials and other approaches in clinical research. Cancer 1994;74 (9 suppl):2610−3.
11. Simons J.P., Aaronson N.K., Vansteenkiste J.F. еt al. Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebocontrolled multicenter study. J Clin Oncol 1996;14(4):1077−84.
Review
For citations:
Sveklina T.A., Krupin V.N. QUALITY OF LIFE IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER STAGES T2B AND T3A AFTER SURGICAL TREATMENT. Cancer Urology. 2012;8(3):55-59. (In Russ.) https://doi.org/10.17650/1726-9776-2012-8-3-55-59
Views:
740
Email this article 